InvestorsHub Logo
Followers 23
Posts 2682
Boards Moderated 0
Alias Born 08/25/2010

Re: Blueheel1 post# 103535

Sunday, 08/09/2020 9:32:30 AM

Sunday, August 09, 2020 9:32:30 AM

Post# of 233596
I think with the safety profile being 64% better than placebo, the efficacy has to be there as well. We've seen viral load reduction in eIND patients. NP stated again there was a statistical significance and more. Dr J. in over 300 clinical trails hasn't seen results that Leronlimab was able to produce.

I would think we have to be better than the current SOC, which should get us EUA for m/m. I'm hoping once the FDA sees the complied data, and knowing that the S/C trails looked good, they will allow for earlier interim.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News